Market Place
Sourcing Support
Novo Nordisk: Wegovy Shows 28% Weight Loss in Early Responders
12 May 2026 //
GLOBENEWSWIRE
Lilly`s Foundayo & Low-Dose Zepbound Help Maintain Weight Loss
12 May 2026 //
PR NEWSWIRE
Semaglutide Race: Torrent Grabs 38% Market Share
08 May 2026 //
ECONOMICTIMES
Novi GLP-1 Weight Loss Options Evaluated With Dedicated Doctors
07 May 2026 //
GLOBENEWSWIRE
Medicare Expands Wegovy Access for Obesity From July 2026
07 May 2026 //
PR NEWSWIRE
Amazon Adds Ozempic Pill To Same-Day Prescription Drug Kiosks
07 May 2026 //
ENDPOINTS
Onesource Supports Second Generic Semaglutide Approval In Canada
05 May 2026 //
EXPRESSPHARMA
OneSource Partners Win Health Canada Nod for Generic Semaglutide
04 May 2026 //
INDPHARMAPOST
Ozempic Maker To Pilot Diabetes, Obesity Treatments In Singapore
03 May 2026 //
FIRSTWORD PHARMA
Affordable Semaglutide & Tirzepatide GLP-1 Program Assessed
01 May 2026 //
GLOBENEWSWIRE
Novo Nordisk Launches Ozempic Oral Pill For Type 2 Diabetes
01 May 2026 //
PR NEWSWIRE
Weight Watchers Expands Med+ With New Ozempic (Semaglutide)
01 May 2026 //
GLOBENEWSWIRE
Goodrx Adds Ozempic Pill For Type 2 Diabetes Patients
01 May 2026 //
PHARMIWEB
Apotex First Canadian Pharma Co. To Get Health Canada Approval
01 May 2026 //
PR NEWSWIRE
U.S. Prescription Drug Spending Poised To Cross $1 Trillion
30 Apr 2026 //
PR NEWSWIRE
FDA Proposes Excluding Semaglutide, Tirzepatide, Liraglutide
30 Apr 2026 //
FDA
Weight-Loss Drugs May Also Help Cut Alcohol Intake: Study
30 Apr 2026 //
ECONOMICTIMES
Onesource Pharma, Dr Reddy`s Secure Health Canada Nod
29 Apr 2026 //
INDPHARMAPOST
Dr Reddy`s Laboratories Receives Approval From Health Canada
29 Apr 2026 //
PRESS RELEASE
Novo Nordisk at ECO: Wegovy & Next-Gen Weight Loss Treatments
28 Apr 2026 //
GLOBENEWSWIRE
Novo Eyes Adolescent Diabetes Approval for Oral Semaglutide
27 Apr 2026 //
FIERCE PHARMA
MHRA Approves 48-Hour Controlled-Temp Storage for Wegovy
23 Apr 2026 //
PHARMIWEB
Experts Scrutinize SkinnyRx`s GLP-1 Semaglutide Claims
23 Apr 2026 //
GLOBENEWSWIRE
Enforcement Report - Week of April 22, 2026
22 Apr 2026 //
FDA
FDA issues warning letter after GLP-1 manufacturer
22 Apr 2026 //
FDA
Onesource And Orbicular Secure USFDA Tentative Approval
21 Apr 2026 //
EXPRESSPHARMA
Ozempic, Mounjaro Weight-Loss Drug Demand Surges In India
19 Apr 2026 //
ECONOMICTIMES
Study Suggests Lilly`s Tirzepatide Causes More Lean Muscle Loss
17 Apr 2026 //
ENDPOINTS
India`s Hetero Targets Annual Sales of 1.5 mln Semaglutide Pens
17 Apr 2026 //
REUTERS
Dr Reddy`s Gets Nod To Roll Out Generic Oral Semaglutide Drug
16 Apr 2026 //
PRESS RELEASE
Wegovy-maker Novo Nordisk partners with OpenAI
16 Apr 2026 //
REUTERS
MSN Labs Launches SEMABEST Semaglutide in India After CDSCO Nod
15 Apr 2026 //
EXPRESSPHARMA
Emcure Pharma Adjusts Poviztra Semaglutide Injection Price
15 Apr 2026 //
EXPRESSPHARMA
GoodRx Introduces Wegovy HD At $399/Month Self-Pay Rate
15 Apr 2026 //
PHARMIWEB
MHRA Approves Single-Dose Injection Device For Wegovy 7.2Mg
14 Apr 2026 //
PHARMIWEB
Retatrutide Ignites Buzz on Weight Loss, Longevity
13 Apr 2026 //
ECONOMICTIMES
The GLP-1 Revolution
13 Apr 2026 //
EXPRESSPHARMA
Apotex Gets Initial U.S. FDA Nod For Generic Ozempic
12 Apr 2026 //
PR NEWSWIRE
IPM Hits Growth in March as Semaglutide Generics Spark gold Rush
11 Apr 2026 //
PHARMABIZ
Mounjaro Sales Decline Due To Semaglutide Generics` Rise
10 Apr 2026 //
ECONOMICTIMES
Novo Nordisk launches higher-dose Wegovy in the United States
10 Apr 2026 //
PRNEWSWIRE
Vanda Kicks Off NEREUS Trial for GLP-1-Induced Nausea
09 Apr 2026 //
PR NEWSWIRE
Generic Drugmakers Rush As Novo Nordisk Loses Weight-Loss Drug
09 Apr 2026 //
ECONOMICTIMES
Novo`s Wegovy: First EU-Approved GLP-1 for 48-Week Use
09 Apr 2026 //
GLOBENEWSWIRE
Experts Weigh Semaglutide Patent Expiry`s GLP-1 Impact
08 Apr 2026 //
PHARMABIZ
23andMe Study Identifies Genetic Predictors of GLP-1 Weight Loss
08 Apr 2026 //
GLOBENEWSWIRE
Diabetes Drug Fuels Growing Weight Loss Trend in India
07 Apr 2026 //
INDPHARMAPOST
Apotex’s Generics Semaglutide Receives Tentative Approval in US
07 Apr 2026 //
FDA
Experts Recommend Comprehensive Semaglutide Utilization
06 Apr 2026 //
INDPHARMAPOST
Government Initiates Safety Review Of Popular Weight-Loss Drugs
04 Apr 2026 //
ECONOMICTIMES
Patent Expiries Ahead, Is India Pharma Inc Ready?
03 Apr 2026 //
EXPRESSPHARMA
Wegovy Pill Shows Greater Weight Loss vs Orforglipron: Analysis
02 Apr 2026 //
PR NEWSWIRE
Emcure Pharma Cuts Poviztra Starting Dose Price By 55% In India
02 Apr 2026 //
INDPHARMAPOST
Midst Global Headwinds, CDSCO Cracks Down On GLP-1 Gold Rush
01 Apr 2026 //
EXPRESSPHARMA
UK Cost Watchdog Clears Novo`s Wegovy For Cardio Risk Reduction
01 Apr 2026 //
FIERCE PHARMA
India`s Weight Management Market Growth Raises Risk
31 Mar 2026 //
BUSINESS STD
Novo Nordisk Slashes Ozempic, Wegovy Prices by Up to 48% in India
31 Mar 2026 //
ECONOMICTIMES
Novo Nordisk Plans To Cut Price Of Ozempic As Generics Hit Market
31 Mar 2026 //
ECONOMICTIMES
Bionxt Progresses Semaglutide In First GLP-1 ODF Platform Move
30 Mar 2026 //
PHARMIWEB
Alkem Labs Introduces Cost-Effective Semaglutide Injection
26 Mar 2026 //
INDPHARMAPOST
